Eversyn

Developer of a biotech company planning to produce nucleotide sugars. The company is designing biocatalysts to manufacture human milk oligosaccharides and customize the glycosylation of therapeutic proteins, enabling biotechnology experts to offer orders at scales with lower production costs than currently available.